Aura Biosciences Inc (AURA)
Healthcare
Biotechnology
7.00 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Aura Biosciences Inc (AURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -85 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -21 | -24 | -32 | -55 | -64 | -80 | -85 | |
| 0.5 | 0.8 | 0.8 | 1.2 | 1.3 | 1.2 | 1.1 | |
| 0.5 | 0.7 | 2.3 | 6.4 | 8.8 | 12 | 14 | |
| 0.6 | 0.7 | 2.3 | 6.1 | – | – | – | |
| 2.5 | -3.7 | -0.3 | -3.1 | 4.4 | -2.6 | 6.0 | |
| 2.2 | 0.8 | 2.1 | 1.1 | 0.7 | 1.3 | 0.4 | |
| -2.2 | -0.8 | -2.1 | -68 | -114 | 69 | 36 | |
| 40 | – | – | – | – | – | – | |
| 0.0 | 0.0 | 166 | 87 | – | – | – | |
| 0.0 | 0.0 | – | – | – | – | – | |
| 40 | 10 | 166 | 96 | 97 | 1.6 | 77 | |
| 17 | -15 | 132 | -27 | -81 | -9.4 | 28 | |
| -23 | -25 | -35 | -56 | -65 | -81 | -85 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.